Advertisement
Screener

RENOVORX, INC. (RNXT) Long-Term Debt, Maturity, Remainder of Fiscal Year

RENOVORX, INC. Long-Term Debt, Maturity, Remainder of Fiscal Year

RENOVORX, INC. (RNXT) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $29.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.

Financial Statements › Notes › Commitment and Contingencies

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2025-11-13

  • 2025-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $29.00K.
  • 2025-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $57.00K.
  • 2025-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $86.00K.
Period endLong-Term Debt, Maturity, Remainder of Fiscal Year
2025-09-30$29.00K
10-Q · filed 2025-11-13
2025-06-30$57.00K
10-Q · filed 2025-08-14
2025-03-31$86.00K
10-Q · filed 2025-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
Pulmonx Corp (LUNG)United States$0.082B-1.16
CVRx, Inc. (CVRX)United States$0.067B-2.62
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
DarioHealth Corp. (DRIO)$0.066B-1.39
LENSAR, Inc. (LNSR)United States$0.087B2.02
Microbot Medical Inc. (MBOT)$0.089B-7.97
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B